Saturday, 3 October 2026European Markets

VASTNED BELGIUM, KLEPIERRE, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Real Estate Sector.

Loading stream...

(vianews) - vastned belgium (vastb.br) is among this list of stock assets with the highest dividend rate and return on equity on the real estate sector.

financial asset price forward dividend yield return on equity
vastned belgium (vastb.br) €31.00 7.59% 5.59%
klepierre (li.pa) €24.00 6.74% 7.56%
selectirente (seler.pa) €88.00 4.68% 5.87%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. vastned belgium (vastb.br)

7.59% forward dividend yield and 5.59% return on equity

vastned belgium is a public regulated real estate company (rrec), the shares of which are listed on euronext brussels (vastb). vastned belgium invests exclusively in belgian commercial real estate, more specifically in multi-functional retail properties located in the popular shopping cities of antwerp, brussels, ghent and bruges. the real estate portfolio also comprises high-end retail parks and retail warehouses. a smaller part of the portfolio is invested in hospitality and residential units.

earnings per share

as for profitability, vastned belgium has a trailing twelve months eps of €2.51.

pe ratio

vastned belgium has a trailing twelve months price to earnings ratio of 12.35. meaning, the purchaser of the share is investing €12.35 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.59%.

dividend yield

as stated by morningstar, inc., the next dividend payment is on may 6, 2024, the estimated forward annual dividend rate is 2.3 and the estimated forward annual dividend yield is 7.59%.

more news about vastned belgium.

2. klepierre (li.pa)

6.74% forward dividend yield and 7.56% return on equity

klépierre sa is the european leader in shopping malls, combining property development and asset management skills. the company's portfolio is valued at €19.3 billion at december 31, 2023, and comprises large shopping centers in more than 10 countries in continental europe which together host hundreds of millions of visitors per year. klépierre sa holds a controlling stake in steen & strøm (56.1%), scandinavia's number one shopping center owner and manager. klépierre sa is a french reit (siic) listed on euronext paris and is included in the cac next 20 and epra euro zone indexes. it is also included in ethical indexes, such as euronext cac 40 esg, euronext cac sbt 1.5, msci europe esg leaders, ftse4good, euronext vigeo europe 120, and features in cdp's “a-list”. these distinctions underscore the group's commitment to a proactive sustainable development policy and its global leadership in the fight against climate change.

earnings per share

as for profitability, klepierre has a trailing twelve months eps of €0.6.

pe ratio

klepierre has a trailing twelve months price to earnings ratio of 40. meaning, the purchaser of the share is investing €40 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.56%.

volatility

klepierre's last week, last month's, and last quarter's current intraday variation average was a negative 0.34%, a positive 0.31%, and a positive 0.90%.

klepierre's highest amplitude of average volatility was 0.91% (last week), 0.75% (last month), and 0.90% (last quarter).

yearly top and bottom value

klepierre's stock is valued at €24.00 at 02:30 est, way below its 52-week high of €27.62 and way above its 52-week low of €21.44.

more news about klepierre.

3. selectirente (seler.pa)

4.68% forward dividend yield and 5.87% return on equity

selectirente is a public real estate fund managed by sofidy. it invests in city center and suburb commercial properties, which should be located close to shopping malls. it primarily acquires properties in france. as of march 29, 2019, selectirente operates as a subsidiary of tikehau capital.

earnings per share

as for profitability, selectirente has a trailing twelve months eps of €2.32.

pe ratio

selectirente has a trailing twelve months price to earnings ratio of 37.93. meaning, the purchaser of the share is investing €37.93 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.87%.

moving average

selectirente's worth is above its 50-day moving average of €85.99 and under its 200-day moving average of €88.85.

yearly top and bottom value

selectirente's stock is valued at €88.00 at 02:30 est, below its 52-week high of €96.00 and higher than its 52-week low of €83.50.

more news about selectirente.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com